As part of a strong campaign against the illegal drug trade in Karnataka, 16 drug licences have been cancelled following the discovery of a huge ₹5.05 crore drug racket.
The FDA started the investigation following intelligence on fake and substandard drugs being circulated in various parts of the state, the FDA said. The drugs were seized in raids at various locations, with counterfeit drugs worth about ₹5.05 crore seized. A network was found to be involved in the production and sale of drugs that were falsely labelled as genuine pharmaceutical products, as well as the distribution of drugs that were sold as fake and substandard medicines.
The seized drugs are those commonly prescribed for various health conditions, the investigators say. The counterfeit drugs were being received from unauthorised sources and distributed to pharmacies and other medical facilities, the FDA said.
The FDA then investigated the role of licensed drug dealers and distributors involved in the racket and examined the role of licensed drug dealers and distributors in the racket. The department cancelled 16 drug licences for violating regulatory standards and involvement in the illegal supply chain based on the evidence gathered in the probe. There will be no doubt of any kind of heavy fines for anyone who is involved in the production, sale, or distribution of counterfeit medicines, officials said.
The Karnataka FDA has also launched legal proceedings against some of the racket participants. Cases have been registered under relevant provisions of the Drugs and Cosmetics Act, and more investigations are going on to find other members of the ring. Financial transactions, supply routes, and procurement records are being examined to establish the full extent of the operation.
Health professionals have welcomed the crackdown, pointing out that counterfeit medicines pose a serious threat to public health. Unlike genuine medicines that undergo rigorous quality testing, fake drugs may contain false ingredients, insufficient active compounds, or harmful substances. These products contribute to increased medical problems, slow recovery, and drug resistance in some diseases.
The FDA said pharmacists, healthcare providers, and consumers should be vigilant while purchasing drugs. Drug buyers should purchase medicines only from licensed pharmacies and verify product details, including packaging, batch numbers, and expiry dates, the agency said. Suspicious products should be reported to the authorities for verification and action.
The latest operation shows the Karnataka government’s commitment to ensuring the safety and quality of medicines available in the market. With counterfeit drug networks becoming increasingly sophisticated, regulatory agencies are strengthening surveillance mechanisms and enforcement measures to prevent illegal products from reaching patients.
So inspections and monitoring efforts will continue across the state, State Health Department officials said. In the coming months, the FDA will conduct more audits of pharmaceutical distributors and retailers to ensure compliance with drug safety regulations and protect public health.
The bust of the ₹5.05 crore fake medicine racket is one of the most significant anti-counterfeit operations in recent years, sending a strong message to those involved in illegal pharmaceutical practices that violations will face severe legal consequences.
